Evidence map›Paper›PMID 34743445›Full record

ArticleJournal of biomedical optics2021

Dimensional reduction based on peak fitting of Raman micro spectroscopy data improves detection of prostate cancer in tissue specimens.

Arthur Plante, Frédérick Dallaire, Andrée-Anne Grosset, Tien Nguyen, Mirela Birlea, Jahg Wong, François Daoust, Noémi Roy, André Kougioumoutzakis, Feryel Azzi and 19 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Journal of biomedical optics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Current Trends of Raman Spectroscopy in Clinic Settings: Opportunities and Challenges.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 7 institutions in 3 countries.

Arthur PlanteCentre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Frédérick DallaireCentre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Andrée-Anne GrossetCentre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Tien NguyenCentre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Mirela BirleaCentre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Jahg WongCentre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
François DaoustCentre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Noémi RoyCentre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
André KougioumoutzakisCentre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Feryel AzziCentre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Kelly AubertinCentre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Samuel KadouryCentre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Mathieu LatourUniversité de Montréal, Department of Pathology and Cellular Biology, Montreal, Quebec, Canada.
Roula AlbadineUniversité de Montréal, Department of Pathology and Cellular Biology, Montreal, Quebec, Canada.
Susan PrendevilleUniversity Health Network, Laboratory Medicine Program, Toronto, Ontario, Canada.
Paul BoutrosInformatics & Biocomputing Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
Michael FraserInformatics & Biocomputing Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
Rob G BristowUniversity Health Network, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Theodorus van der KwastUniversity Health Network, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Michèle OrainCentre de recherche du Centre hospitalier universitaire de Québec-Université Laval, Oncology Divisio, Canada.
Hervé BrissonCentre de recherche du Centre hospitalier universitaire de Québec-Université Laval, Oncology Divisio, Canada.
Nazim BenzerdjebCentre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Hélène HovingtonCentre de recherche du Centre hospitalier universitaire de Québec-Université Laval, Oncology Divisio, Canada.
Alain BergeronCentre de recherche du Centre hospitalier universitaire de Québec-Université Laval, Oncology Divisio, Canada.
Yves FradetCentre de recherche du Centre hospitalier universitaire de Québec-Université Laval, Oncology Divisio, Canada.
Bernard TêtuCentre de recherche du Centre hospitalier universitaire de Québec-Université Laval, Oncology Divisio, Canada.
Fred SaadCentre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Dominique TrudelCentre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Frédéric LeblondCentre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Centre Hospitalier de l’Université de Montréal · CAUniversité Laval · CABiocom · USUniversité de Montréal · CAUniversity Health Network · CAInserm · FRPrincess Margaret Cancer Centre · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

significanceProstate cancer is the most common cancer among men. An accurate diagnosis of its severity at detection plays a major role in improving their survival. Recently, machine learning models using biomarkers identified from Raman micro-spectroscopy discriminated intraductal carcinoma of the prostate (IDC-P) from cancer tissue with a ≥85  %   detection accuracy and differentiated high-grade prostatic intraepithelial neoplasia (HGPIN) from IDC-P with a ≥97.8  %   accuracy.

aimTo improve the classification performance of machine learning models identifying different types of prostate cancer tissue using a new dimensional reduction technique. APPROACH: A radial basis function (RBF) kernel support vector machine (SVM) model was trained on Raman spectra of prostate tissue from a 272-patient cohort (Centre hospitalier de l'Université de Montréal, CHUM) and tested on two independent cohorts of 76 patients [University Health Network (UHN)] and 135 patients (Centre hospitalier universitaire de Québec-Université Laval, CHUQc-UL). Two types of engineered features were used. Individual intensity features, i.e., Raman signal intensity measured at particular wavelengths and novel Raman spectra fitted peak features consisting of peak heights and widths.

resultsCombining engineered features improved classification performance for the three aforementioned classification tasks. The improvements for IDC-P/cancer classification for the UHN and CHUQc-UL testing sets in accuracy, sensitivity, specificity, and area under the curve (AUC) are (numbers in parenthesis are associated with the CHUQc-UL testing set): +4  %   (+8  %  ), +7  %   (+9  %  ), +2  %   (6%), +9 (+9) with respect to the current best models. Discrimination between HGPIN and IDC-P was also improved in both testing cohorts: +2.2  %   (+1.7  %  ), +4.5  %   (+3.6  %  ), +0  %   (+0  %  ), +2.3 (+0). While no global improvements were obtained for the normal versus cancer classification task [+0  %   (-2  %  ), +0  %   (-3  %  ), +2  %   (-2  %  ), +4 (+3)], the AUC was improved in both testing sets.

conclusionsCombining individual intensity features and novel Raman fitted peak features, improved the classification performance on two independent and multicenter testing sets in comparison to using only individual intensity features.

Indexed as

Carcinoma, Intraductal, NoninfiltratingProstatic NeoplasmsArea Under CurveHumansMachine LearningMaleSpectrum Analysis, Ramanfeature reductionfeature selectionmachine learningprostate cancerRaman micro-spectroscopy

Identifiers

PMID34743445
PMCPMC8571651
OpenAlexW3212938543

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.